Opaleye Management Inc., 10% Owner at Eton Pharmaceuticals, Inc. (ETON), sold 126,685 shares at $37.39 ($4.8M) on 2026-07-02, disclosed to the SEC on 2026-07-07.
Open-market sale of $4.8M ETON by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.39 | 25,000 | $935K | 19.6% |
| 2 | $37.39 | 65,000 | $2.4M | 51.0% |
| 3 | $38.00 | 10,000 | $380K | 8.0% |
| 4 | $38.37 | 6,685 | $257K | 5.4% |
| 5 | $38.37 | 20,000 | $767K | 16.1% |
| Total | $37.64 avg | 126,685 |
| $4.8M |
| 100% |
| Filing → |
| GRCE | BUY | 2026-10-01 | $16K | — | Filing → |
| GRCE | BUY | 2026-09-23 | $32K | — | Filing → |
| ACOG | BUY | 2026-09-16 | $1.1M | — | Filing → |